PPH holdings
VanEck Pharmaceutical ETF
Positions
26 stored of 26 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 532457108 | 20.230% | $177.9M | Equity (common) | Corporate | United States | USD |
| 2 | Novartis AG | US66987V1098 | 66987V109 | 10.625% | $93.4M | Equity (common) | Corporate | Switzerland | USD |
| 3 | Merck & Co Inc | US58933Y1055 | 58933Y105 | 9.845% | $86.6M | Equity (common) | Corporate | United States | USD |
| 4 | Novo Nordisk A/S | US6701002056 | 670100205 | 5.366% | $47.2M | Equity (common) | Corporate | Denmark | USD |
| 5 | AbbVie Inc | US00287Y1091 | 00287Y109 | 4.575% | $40.2M | Equity (common) | Corporate | United States | USD |
| 6 | Pfizer Inc | US7170811035 | 717081103 | 4.507% | $39.6M | Equity (common) | Corporate | United States | USD |
| 7 | Bristol-Myers Squibb Co | US1101221083 | 110122108 | 4.469% | $39.3M | Equity (common) | Corporate | United States | USD |
| 8 | GSK PLC | US37733W2044 | 37733W204 | 4.418% | $38.9M | Equity (common) | Corporate | United Kingdom | USD |
| 9 | Johnson & Johnson | US4781601046 | 478160104 | 4.355% | $38.3M | Equity (common) | Corporate | United States | USD |
| 10 | AstraZeneca PLC | GB0009895292 | Not reported | 4.333% | $38.1M | Equity (common) | Corporate | United Kingdom | USD |
| 11 | McKesson Corp | US58155Q1031 | 58155Q103 | 4.122% | $36.3M | Equity (common) | Corporate | United States | USD |
| 12 | Sanofi SA | US80105N1054 | 80105N105 | 4.004% | $35.2M | Equity (common) | Corporate | France | USD |
| 13 | Cencora Inc | US03073E1055 | 03073E105 | 3.356% | $29.5M | Equity (common) | Corporate | United States | USD |
| 14 | Haleon PLC | US4055521003 | 405552100 | 3.091% | $27.2M | Equity (common) | Corporate | United Kingdom | USD |
| 15 | Teva Pharmaceutical Industries Ltd | US8816242098 | 881624209 | 3.058% | $26.9M | Equity (common) | Corporate | Israel | USD |
| 16 | Takeda Pharmaceutical Co Ltd | US8740602052 | 874060205 | 2.872% | $25.3M | Equity (common) | Corporate | Japan | USD |
| 17 | Zoetis Inc | US98978V1035 | 98978V103 | 2.099% | $18.5M | Equity (common) | Corporate | United States | USD |
| 18 | Viatris Inc | US92556V1061 | 92556V106 | 1.095% | $9.6M | Equity (common) | Corporate | United States | USD |
| 19 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | Not reported | 1.081% | $9.5M | Equity (common) | Corporate | Ireland | USD |
| 20 | Axsome Therapeutics Inc | US05464T1043 | 05464T104 | 0.768% | $6.8M | Equity (common) | Corporate | United States | USD |
| 21 | Corcept Therapeutics Inc | US2183521028 | 218352102 | 0.504% | $4.4M | Equity (common) | Corporate | United States | USD |
| 22 | Elanco Animal Health Inc | US28414H1032 | 28414H103 | 0.353% | $3.1M | Equity (common) | Corporate | United States | USD |
| 23 | State Street Global Advisors State Street Navigator Securities Lending Government Money Market Portfolio | US8575093013 | 857509301 | 0.276% | $2.4M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 24 | Organon & Co | US68622V1061 | 68622V106 | 0.229% | $2.0M | Equity (common) | Corporate | United States | USD |
| 25 | Bausch Health Cos Inc | CA0717341071 | 071734107 | 0.098% | $861K | Equity (common) | Corporate | Canada | USD |
| 26 | Perrigo Co PLC | IE00BGH1M568 | Not reported | 0.060% | $528K | Equity (common) | Corporate | Ireland | USD |